Seguir
C.Willemien Menke-van der Houven van Oordt
C.Willemien Menke-van der Houven van Oordt
Afiliación desconocida
Dirección de correo verificada de vumc.nl
Título
Citado por
Citado por
Año
MDMX: a novel p53‐binding protein with some functional properties of MDM2.
A Shvarts, WT Steegenga, N Riteco, T Van Laar, P Dekker, M Bazuine, ...
The EMBO journal 15 (19), 5349-5357, 1996
8081996
The Mkk3/6-p38–Signaling Cascade Alters the Subcellular Distribution of Hnrnp A1 and Modulates Alternative Splicing Regulation
W van der Houven van Oordt, MT Diaz-Meco, J Lozano, AR Krainer, ...
The Journal of cell biology 149 (2), 307-316, 2000
4492000
Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR …
G Gebhart, LE Lamberts, Z Wimana, C Garcia, P Emonts, L Ameye, ...
Annals of oncology 27 (4), 619-624, 2016
3532016
Neutrophils kill antibody-opsonized cancer cells by trogoptosis
HL Matlung, L Babes, XW Zhao, M van Houdt, LW Treffers, DJ van Rees, ...
Cell reports 23 (13), 3946-3959. e6, 2018
3242018
Isolation and identification of the human homolog of a new p53-binding protein, Mdmx
A Shvarts, M Bazuine, P Dekker, YFM Ramos, WT Steegenga, G Merckx, ...
Genomics 43 (1), 34-42, 1997
1951997
Immuno-positron emission tomography with zirconium-89-labeled monoclonal antibodies in oncology: what can we learn from initial clinical trials?
YWS Jauw, CW Menke-van der Houven van Oordt, OS Hoekstra, ...
Frontiers in pharmacology 7, 131, 2016
1662016
Apc1638N: a mouse model for familial adenomatous polyposis–associated desmoid tumors and cutaneous cysts
R Smits, WH van Oordt, A Luz, C Zurcher, S Jagmohan-Changur, ...
Gastroenterology 114 (2), 275-283, 1998
1511998
Antibody positron emission tomography imaging in anticancer drug development
LE Lamberts, SP Williams, AGT Terwisscha van Scheltinga, ...
Journal of Clinical Oncology 33 (13), 1491-1504, 2015
1292015
89Zr-cetuximab PET imaging in patients with advanced colorectal cancer
CW Menke-van der Houven, EC Gootjes, MC Huisman, DJ Vugts, C Roth, ...
Oncotarget 6 (30), 30384, 2015
1092015
First-in-human phase I clinical trial of RG7356, an anti-CD44 humanized antibody, in patients with advanced, CD44-expressing solid tumors
CW Menke-van der Houven, C Gomez-Roca, C van Herpen, AL Coveler, ...
Oncotarget 7 (48), 80046, 2016
882016
Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study
AH Eijkelboom, L de Munck, MJTFD Vrancken Peeters, MJM Broeders, ...
Journal of hematology & oncology 14, 1-12, 2021
852021
ImmunoPET with anti-mesothelin antibody in patients with pancreatic and ovarian cancer before anti-mesothelin antibody–drug conjugate treatment
LE Lamberts, CW Menke-van der Houven van Oordt, EJ Ter Weele, ...
Clinical Cancer Research 22 (7), 1642-1652, 2016
792016
Androgen and estrogen receptor imaging in metastatic breast cancer patients as a surrogate for tissue biopsies
CM Venema, LH Mammatas, CP Schröder, M van Kruchten, G Apollonio, ...
Journal of Nuclear Medicine 58 (12), 1906-1912, 2017
632017
Role of SR protein modular domains in alternative splicing specificity in vivo
W van der Houven van Oordt, K Newton, GR Screaton, JF Cáceres
Nucleic Acids Research 28 (24), 4822-4831, 2000
632000
Comparative biodistribution analysis across four different 89Zr-monoclonal antibody tracers—The first step towards an imaging warehouse
F Bensch, MM Smeenk, SC van Es, JR de Jong, CP Schröder, SF Oosting, ...
Theranostics 8 (16), 4295, 2018
572018
The influence of adjuvant systemic regimens on contralateral breast cancer risk and receptor subtype
I Kramer, M Schaapveld, HSA Oldenburg, GS Sonke, D McCool, ...
JNCI: Journal of the National Cancer Institute 111 (7), 709-718, 2019
542019
Radiomics analysis of pre-treatment [18F]FDG PET/CT for patients with metastatic colorectal cancer undergoing palliative systemic treatment
EJ Van Helden, YJL Vacher, WN Van Wieringen, FHP Van Velden, ...
European journal of nuclear medicine and molecular imaging 45, 2307-2317, 2018
532018
Immuno-PET imaging to assess target engagement: Experience from 89Zr-anti-HER3 mAb (GSK2849330) in patients with solid tumors
CW Menke-Van Der Houven, A McGeoch, M Bergstrom, I McSherry, ...
Journal of Nuclear Medicine 60 (7), 902-909, 2019
522019
Non-invasive tumor genotyping using radiogenomic biomarkers, a systematic review and oncology-wide pathway analysis
RW Jansen, P van Amstel, RM Martens, IE Kooi, P Wesseling, ...
Oncotarget 9 (28), 20134, 2018
512018
PET/CT-derived whole-body and bone marrow dosimetry of 89Zr-cetuximab
NE Makris, R Boellaard, A van Lingen, AA Lammertsma, ...
Journal of Nuclear Medicine 56 (2), 249-254, 2015
492015
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20